OMC
Overbrook Management Corp’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Sell |
48,208
-10,200
| -17% | -$368K | 0.32% | 31 |
|
|
2025
Q1 | $1.82M | Sell |
58,408
-60,000
| -51% | -$1.87M | 0.43% | 31 |
|
|
2024
Q4 | $3.02M | Sell |
118,408
-22,500
| -16% | -$574K | 0.65% | 30 |
|
|
2024
Q3 | $3.99M | Sell |
140,908
-59,504
| -30% | -$1.68M | 0.91% | 27 |
|
|
2024
Q2 | $5.28M | Sell |
200,412
-8,937
| -4% | -$236K | 1.33% | 26 |
|
|
2024
Q1 | $6.36M | Sell |
209,349
-10,328
| -5% | -$314K | 1.71% | 23 |
|
|
2023
Q4 | $6.17M | Sell |
219,677
-79,035
| -26% | -$2.22M | 1.25% | 22 |
|
|
2023
Q3 | $8.11M | Sell |
298,712
-255,005
| -46% | -$6.92M | 1.89% | 22 |
|
|
2023
Q2 | $17M | Sell |
553,717
-25,066
| -4% | -$771K | 4.04% | 10 |
|
|
2023
Q1 | $20.9M | Sell |
578,783
-30,569
| -5% | -$1.1M | 5.46% | 5 |
|
|
2022
Q4 | $24.1M | Sell |
609,352
-19,550
| -3% | -$773K | 7% | 4 |
|
|
2022
Q3 | $25.3M | Sell |
628,902
-71,169
| -10% | -$2.86M | 7.18% | 3 |
|
|
2022
Q2 | $29.4M | Sell |
700,071
-23,179
| -3% | -$974K | 8.51% | 2 |
|
|
2022
Q1 | $28.2M | Sell |
723,250
-5,875
| -0.8% | -$229K | 6.25% | 2 |
|
|
2021
Q4 | $29.1M | Sell |
729,125
-56,007
| -7% | -$2.23M | 5.86% | 3 |
|
|
2021
Q3 | $28.4M | Buy |
785,132
+28,011
| +4% | +$1.01M | 6.16% | 2 |
|
|
2021
Q2 | $31M | Sell |
757,121
-14,034
| -2% | -$575K | 6.49% | 2 |
|
|
2021
Q1 | $33.6M | Sell |
771,155
-7,356
| -0.9% | -$321K | 7.48% | 2 |
|
|
2020
Q4 | $39M | Buy |
778,511
+670,759
| +623% | +$33.6M | 9.51% | 1 |
|
|
2020
Q3 | $4.53M | Buy |
+107,752
| New | +$4.53M | 1.05% | 24 |
|